Recent research has linked Elmiron, a popular medication prescribed for interstitial cystitis (painful bladder syndrome), with a unique form of progressive eye disease- typically diagnosed by ophthalmologists as retinal pigmentary maculopathy, pattern dystrophy or age- related macular degeneration.
Symptoms of Elmiron-associated retinal maculopathy include:
- Difficulty reading
- Difficulty adapting to dim lighting
- Blurred vision (often in the central field of vision)
- Dark spots in center of vision
- Straight lines appearing curved or squiggly
- Less vivid colors
Unfortunately, the damage can continue to occur even after a patient stops taking Elmiron. If you have ever taken Elmiron you should get your eyes examined by an ophthalmologist to check for pigmentary maculopathy.
To date the manufacturer has not updated the warnings or voluntarily withdrawn the drug from the market despite these findings.
If you are diagnosed with pigmentary maculopathy and have taken Elmiron you may have a claim against the manufacturer for your injury. If you would like more information about the risks or believe you may have a claim, please feel free to contact us.
